COF
63
-7
KMI
40
-6
OKE
43
-5
DLTR
56
-2
STI
39
5
PBI
49
-4
CNX
48
-7
SLG
55
-4
GWW
39
-4
EXC
43
-14
BRK.B
31
-2
ALLE
30
-5
GPC
53
-5
AIV
47
-3
SEE
45
-4
APH
58
-4
MAC
41
-5
DIS
58
-2
IFF
60
-2
MHK
49
-7
COF
63
-7
KMI
40
-6
OKE
43
-5
DLTR
56
-2
STI
39
5
PBI
49
-4
CNX
48
-7
SLG
55
-4
GWW
39
-4
EXC
43
-14
BRK.B
31
-2
ALLE
30
-5
GPC
53
-5
AIV
47
-3
SEE
45
-4
APH
58
-4
MAC
41
-5
DIS
58
-2
IFF
60
-2
MHK
49
-7
Financhill
Back

Brown-Forman 10K Form

Sell
46

BF.B
Brown-Forman

Last Price:
$27.70
Seasonality Move:
1.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BF.B News And Ratings

See the #1 stock for the next 7 days that we like better than BF.B

BF.B Financial Statistics

Sales & Book Value

Annual Sales: $4B
Cash Flow: $102M
Price / Cash Flow: 30.36
Annual Sales: $8.46
Price / Book: 3.28

Profitability

EPS (TTM): 1.84000
Net Income (TTM): $869M
Gross Margin: $2.3B
Return on Equity: 23.48%
Return on Assets: 10.63%

Brown-Forman Earnings Forecast

Key Brown-Forman Financial Ratios

  • The Gross Profit Margin over the past 42 years for BF.B is 58.94%.
  • The Selling, General & Administrative Expenses for BF.B have been equal to 30.89% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 14.04% of Operating Income.
  • The Net Earning history of BF.B is 21.86% of Total Revenues.
  • Per Share Earnings over the last 42 years have been positive in 32 years.

Brown-Forman Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Beverages
Sector: Consumer Staples
Current Symbol: BF.B
Website: brown-forman.com

Debt

Debt-to-Equity Ratio: 0.68
Current Ratio: 3.88
Quick Ratio: 1.18

Price-to-Earnings

Trailing P/E Ratio: 15.04
Forward P/E Ratio: 15.93

BF.B Technical Analysis vs Fundamental Analysis

Sell
46
Brown-Forman (BF.B) is a Sell

Is Brown-Forman a Buy or a Sell?

  • Brown-Forman stock is rated a Sell
    The current Brown-Forman [BF.B] share price is $27.67. The Score for BF.B is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.